499 results on '"Harjola, Veli-Pekka"'
Search Results
2. Quantifying Hemodynamic Cardiac Stress and Cardiomyocyte Injury in Normotensive and Hypertensive Acute Heart Failure
3. Effect of Inhaled Xenon on Cardiac Function in Comatose Survivors of Out-of-Hospital Cardiac Arrest—A Substudy of the Xenon in Combination With Hypothermia After Cardiac Arrest Trial
4. Low body temperature and mortality in older patients with frailty in the emergency department
5. Soluble triggering receptor expressed on myeloid cells-1 is a marker of organ injuries in cardiogenic shock: results from the CardShock Study
6. Characteristics and costs of electric scooter injuries in Helsinki: a retrospective cohort study
7. The emergency department arrival mode and its relations to ED management and 30-day mortality in acute heart failure: an ancillary analysis from the EURODEM study
8. miR‐619‐5p and cardiogenic shock in patients with ST‐segment elevation myocardial infarction.
9. Inhaled Xenon Attenuates Myocardial Damage in Comatose Survivors of Out-of-Hospital Cardiac Arrest The Xe-Hypotheca Trial
10. Venous lactate improves the prediction of in-hospital adverse outcomes in normotensive pulmonary embolism
11. Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).
12. Diagnosis and treatment of right ventricular failure secondary to acutely increased right ventricular afterload (acute cor pulmonale): a clinical consensus statement of the Association for Acute CardioVascular Care of the European Society of Cardiology.
13. Reply to: High levels of plasma biomarkers at 24 h were found to be strong predictors of 90-day mortality: beware of some potential confounders!
14. Systematic geriatric assessment for older patients with frailty in the emergency department: a randomised controlled trial
15. Effect of Inhaled Xenon on Cerebral White Matter Damage in Comatose Survivors of Out-of-Hospital Cardiac Arrest: A Randomized Clinical Trial
16. Levels of Growth Differentiation Factor 15 and Early Mortality Risk Stratification in Cardiogenic Shock
17. Comparative Analysis of Short-Term Outcomes of Patients With Heart Failure With a Mid-Range Ejection Fraction After Acute Decompensation
18. Prevalence, Temporal Evolution, and Impact on Survival of Ventricular Conduction Blocks in Patients With Acute Coronary Syndrome and Cardiogenic Shock
19. Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial Infarction
20. Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use
21. National Early Warning Score 2 (NEWS2) and 3-level triage scale as risk predictors in frail older adults in the emergency department
22. Frequency and Prognostic Significance of Abnormal Liver Function Tests in Patients With Cardiogenic Shock
23. Triage quality control is missing tools—a new observation technique for ED quality improvement
24. The impact of emergency medical services in acute heart failure
25. Use of noninvasive and invasive mechanical ventilation in cardiogenic shock: A prospective multicenter study
26. The association of admission blood glucose level with the clinical picture and prognosis in cardiogenic shock – Results from the CardShock Study
27. Levosimendan beyond inotropy and acute heart failure: Evidence of pleiotropic effects on the heart and other organs: An expert panel position paper
28. The role of levosimendan in acute heart failure complicating acute coronary syndrome: A review and expert consensus opinion
29. Short-term outcomes of heart failure patients with reduced and preserved ejection fraction after acute decompensation according to the final destination after emergency department care
30. Epinephrine and short-term survival in cardiogenic shock: an individual data meta-analysis of 2583 patients
31. Management of cardiogenic shock complicating myocardial infarction
32. Effects of the intensity of prehospital treatment on short-term outcomes in patients with acute heart failure: the SEMICA-2 study
33. Association between hypo- and hyperkalemia and outcome in acute heart failure patients: the role of medications
34. Adrenomedullin: a marker of impaired hemodynamics, organ dysfunction, and poor prognosis in cardiogenic shock
35. Effect of baseline characteristics on mortality in the SURVIVE trial on the effect of levosimendan vs dobutamine in acute heart failure: Sub-analysis of the Finnish patients
36. N-terminal Pro-brain Natriuretic Peptide, High-sensitivity Troponin and Pulmonary Artery Clot Score as Predictors of Right Ventricular Dysfunction in Echocardiography
37. Epidemiology of patients presenting with dyspnea to emergency departments in Europe and the Asia-Pacific region
38. Pulmonary embolism location is associated with the co-existence of the deep venous thrombosis
39. Rapid cardiothoracic ultrasound protocol for diagnosis of acute heart failure in the emergency department
40. Acute heart failure and valvular heart disease: A scientific statement of the Heart Failure Association, the Association for Acute CardioVascular Care and the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology
41. Comparison of the use of comprehensive point-of-care test panel to conventional laboratory process in emergency department
42. IMPROV-ED study: outcomes after discharge for an episode of acute-decompensated heart failure and comparison between patients discharged from the emergency department and hospital wards
43. Acute Heart Failure With and Without Concomitant Acute Coronary Syndromes: Patient Characteristics, Management, and Survival
44. High-Sensitivity Troponin T and Risk Stratification in Patients With Atrial Fibrillation During Treatment With Apixaban or Warfarin
45. Levosimendan in Acute and Advanced Heart Failure: An Appraisal of the Clinical Database and Evaluation of Its Therapeutic Applications
46. Heart failure oral therapies at discharge are associated with better outcome in acute heart failure: a propensity‐score matched study
47. Long‐term safety of intravenous cardiovascular agents in acute heart failure: results from the European Society of Cardiology Heart Failure Long‐Term Registry
48. Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology
49. Epidemiology and one‐year outcomes in patients with chronic heart failure and preserved, mid‐range and reduced ejection fraction: an analysis of the ESC Heart Failure Long‐Term Registry
50. Morphine Use in the ED and Outcomes of Patients With Acute Heart Failure: A Propensity Score-Matching Analysis Based on the EAHFE Registry
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.